Organ Preservation Market

Rising number of organ transplantation procedures worldwide driving the market growth

Moreover, several awareness efforts are projected to affect the industry favorably. The 12th of October, for instance, is recognized as European Day for Organ Donation and Transplantation. In addition, 41,000 patients received organ transplants in Europe in 2018, according to a report released by the Council of Europe in 2019. Hence, it is projected that these occurrences will encourage the expansion of the organ preservation industry during the coming years. Thus, this factor is driving the market CAGR. The rate of kidney transplants is anticipated to increase due to the rising number of renal failure cases and chronic kidney illnesses.

The Centers for Disease Control & Prevention (CDC) reported in 2019 that approximately 15.00% of adults in the United States had chronic kidney disease yearly. Similarly, the National Institute of Diabetes and Digestive and Kidney Diseases reported in 2019 that over 661,000 Americans have kidney failure, of which 468,000 people are on dialysis, and about 193,000 have undergone kidney transplantation. 

Consequently, it is projected that these factors will fuel the expansion of the organ transplantation market throughout the next years. Thus, it is anticipated that this aspect will accelerate Organ Preservation market revenue globally.

Government initiatives aimed at improving organ donation rates and preservation methods play a vital role in the Global Organ Preservation Market Industry. Various countries are implementing policies to enhance organ donation awareness and support research in preservation technologies. For instance, funding for organ preservation research has seen a notable increase, facilitating the development of innovative solutions. Such initiatives are expected to contribute to the market's growth, with an anticipated increase from 0.34 USD Billion in 2024 to 0.62 USD Billion by 2035. This supportive environment fosters collaboration between public and private sectors, ultimately benefiting the organ preservation landscape.

The increasing prevalence of chronic diseases and organ failures globally drives the demand for organ transplants. As the Global Organ Preservation Market Industry expands, the need for effective preservation techniques becomes paramount. In 2024, the market is valued at 0.34 USD Billion, reflecting the urgent requirement for innovative solutions to extend organ viability. This trend is expected to continue, with projections indicating a market growth to 0.62 USD Billion by 2035. The rising number of transplant procedures necessitates advancements in preservation technologies, thereby propelling the Global Organ Preservation Market Industry forward.

Emerging markets are becoming increasingly important in the Global Organ Preservation Market Industry. Countries with developing healthcare infrastructures are recognizing the need for advanced organ preservation techniques to address rising transplant demands. As these markets expand, they present new opportunities for growth and innovation in preservation technologies. The market is expected to grow from 0.34 USD Billion in 2024 to 0.62 USD Billion by 2035, driven by the increasing adoption of preservation methods in these regions. This expansion not only enhances access to transplantation but also stimulates research and development efforts, fostering a more robust global organ preservation ecosystem.

The growing awareness surrounding organ donation significantly impacts the Global Organ Preservation Market Industry. Educational campaigns and advocacy efforts are enhancing public understanding of the importance of organ donation, leading to increased donor registrations. As more individuals become aware of the critical need for organ transplants, the demand for effective preservation methods rises. This trend is likely to contribute to the market's growth, as the need for reliable preservation techniques becomes more pronounced. The interplay between awareness and preservation technology is crucial for ensuring that donated organs are viable for transplantation, thereby supporting the overall health care system.

Technological innovations in organ preservation methods significantly influence the Global Organ Preservation Market Industry. Techniques such as hypothermic machine perfusion and normothermic perfusion are gaining traction, enhancing organ viability and function post-transplant. These advancements are crucial as they address the challenges of ischemic damage and improve transplant outcomes. The market is projected to grow at a CAGR of 5.68% from 2025 to 2035, indicating a robust interest in developing more efficient preservation technologies. As these technologies evolve, they are likely to reshape the landscape of organ preservation, ensuring better patient outcomes and increased organ availability.

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Organ Preservation market accounted for USD 0.137 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. The main drivers of growth are the increasing acceptance of cutting-edge healthcare technologies, the high prevalence of chronic renal disease and heart failure, better reimbursement rules, and rising investments in expanding healthcare infrastructure. 

The regional market is also anticipated to rise due to the aging population and an increase in organ transplant surgeries. New product development, partnerships, partnerships, expansions, mergers, and acquisitions are the main strategies used by the organisations in the market.

Further, the major countries studied in the market report are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Organ Preservation market accounts for the second-largest market share. The demand for facilities for lever preservation for transplants has been further stimulated by the costs associated with healthcare in European nations. The demand for organ transplant surgeries in this area would be further augmented by the incidence of additional severe disorders linked to the cardiovascular and renal systems. Moreover, UK market of Organ Preservation held the largest market share, and the Germany market of Organ Preservation was the fastest growing market in the region.

Asia Pacific Organ Preservation Market is expected to grow at the fastest CAGR from 2022 to 2030. This can be attributed to expanding patient awareness, rising healthcare costs, and growing demand for organ transplant treatments. In the years to come, it is also projected that the aging population, increased kidney and heart failure rates, and rising healthcare costs will contribute to the market's expansion. Further, the China market of Organ Preservation held the largest market share, and the India market of Organ Preservation was the fastest-growing market in the region.

Major market players are spending a lot of money on R&D to increase their product lines, which will help the Organ Preservation market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the Organ Preservation industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the  Organ Preservation industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Organ Preservation industry has provided medicine with some of the most significant benefits. The Organ Preservation market major player such Bristol Myers Squibb, Artivion Inc, Xvivo Perfusion AB, Accord Healthcare Limited, BioLife Solutions Inc, Shanghai Genext Medical Technology Co.Ltd.

Mimetas is a privately held biotechnology firm that creates goods and tissue models of human organs on a chip for drug development. The organization also does chemical testing with food and tailored medical applications. OrganoPlate Caco-2, a product line for organs on a chip, was introduced by MIMETAS in March 2020. Thirty-eight intestinal tubules formed in this product while flowing against an extracellular matrix. This product's development aimed to make Organ-on-a-Chip technology accessible to everyone. As a result, it is projected that this campaign will improve the company's market share.

Organ transport and preservation devices are made, sold, and designed by Paragonix Technologies to protect organs while they are being transported from donors to recipients. Our distinguished products reduce risk in a setting with high stakes. The Paragonix SherpaPak systems combine clinically tested and medically regarded cold preservation procedures in a revolutionary suspension system to offer unrivaled thermal and physical protection. The LIVERguard Donor Liver Preservation System was launched in both the US and Europe in November 2021 by Paragonix Technologies, a producer of donor organ preservation and transit systems.